Selected article for: "blot analysis and western blot analysis"
Author: Lee, Hyojin; Kim, Eun-Ju; Song, Jae-Young; Choi, Jeong Soo; Lee, Ji Youn; Cho, In-Soo; Shin, Yeun-Kyung
Title: Development and evaluation of a competitive enzyme-linked immunosorbent assay using a monoclonal antibody for diagnosis of severe fever with thrombocytopenia syndrome virus in bovine sera
  • Document date: 2016_9_20
    • ID: 0pe8vgin_21
    Snippet: The gene for the recombinant NP was amplified from the commercially synthesized S fragment of SFTSV (GenBank accession No. HQ141612) and cloned into a protein expression vector. A 34 kDa recombinant protein band was well maintained after all purification procedures (Fig. 1 ). This recombinant NP was used as the antigen to generate polyclonal and mAbs. NP-specific polyclonal antibody was obtained in rabbits after four antigen immunizations, and th.....
    Document: The gene for the recombinant NP was amplified from the commercially synthesized S fragment of SFTSV (GenBank accession No. HQ141612) and cloned into a protein expression vector. A 34 kDa recombinant protein band was well maintained after all purification procedures (Fig. 1 ). This recombinant NP was used as the antigen to generate polyclonal and mAbs. NP-specific polyclonal antibody was obtained in rabbits after four antigen immunizations, and the titer of the antibody was tested by IFA and Western blotting (Fig. 2) . NP-specific mAbs were produced from the spleen hybridoma cells of immunized mice, and the three clones (6D55, 8F31, and 10G7) showed strong interactions in the IFA and Western blot tests; therefore, these clones were used as competitive antibodies to develop the cELISA. A clear band corresponding to the size of NP, which appeared only after SFTSV infection, was observed upon Western blot analysis with all generated antibodies (panel A in Fig. 2) . Moreover, IFA using these antibodies showed intense cytoplasmic staining, specifically in Fig. 2) .

    Search related documents:
    Co phrase search for related documents
    • antibody titer and polyclonal antibody: 1, 2, 3, 4, 5
    • antibody titer and protein band: 1
    • antibody titer and protein expression: 1, 2, 3, 4, 5, 6, 7
    • antibody titer and western blotting: 1, 2, 3, 4, 5, 6
    • antigen immunization and generate antibody: 1
    • antigen immunization and polyclonal antibody: 1
    • antigen immunization and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antigen immunization and protein expression vector: 1, 2
    • antigen immunization and SFTSV infection: 1
    • antigen immunization and western blotting: 1, 2
    • blot analysis and clear band: 1
    • blot analysis and cytoplasmic staining: 1
    • blot analysis and hybridoma cell: 1, 2, 3
    • blot analysis and polyclonal antibody: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • blot analysis and protein band: 1, 2, 3, 4
    • blot analysis and protein expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • blot analysis and protein expression vector: 1, 2, 3, 4, 5, 6
    • blot analysis and strong interaction: 1
    • blot analysis and western blotting: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13